Urology Times Newsletter

MEN’S HEALTH MONDAY

Urology Times interviewed four leading urologists who are experts in BPH to get their take on the most important BPH studies of 2018 and 2019.

Learn more

Peyronie’s treatments costs, outcomes compared

Researchers comparing cost and outcomes for surgery, collagenase clostridium histolyticum (CCH [Xiaflex]), and RestoreX traction therapy for Peyronie’s disease found traction is the most cost-effective option for achieving 20% or greater curvature improvement, but CCH or surgery might be more cost-effective and efficacious in specific scenarios.

Get the data

SURVEY

Is DRE still a relevant tool in the management of prostate cancer?

Meeting the challenge: contrast CT and reconstructed models

Oliver Wiseman, MD, discusses how detailed imaging techniques equipped him to locate a patient’s calyceal diverticulum, as well as recognize a very narrow infundibula that would necessitate a specific treatment strategy.

Watch this case study now.